Butyrate-induced GPR41 Activation Inhibits Histone Acetylation and Cell Growth

Journal of Genetics and Genomics

Volumn 39, Issue 8, 2012, Pages 375-384

  Wu, Jin ^a,b   Zhou, Zongli ^a,b   Hu, Yinghe ^a,b   Dong, Suzhen ^a,b  

^a EAST CHINA NORMAL UNIVERSITY   (China)

^b B326 Science Building   (China)

Author keywords

Anti proliferation; Butyrate; Cell cycle arrest; GPR41; HDAC inhibitor

Indexed keywords

BUTYRIC ACID; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 41; HISTONE H3; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BIOCHEMISTRY; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; G1 PHASE CELL CYCLE CHECKPOINT; GROWTH INHIBITION; HISTONE ACETYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION;

ACETYLATION; ANIMALS; APOPTOSIS; BUTYRATES; CELL CYCLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; HISTONES; HUMANS; RECEPTORS, G-PROTEIN-COUPLED;

MAMMALIA;

EID: 84865012300     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2012.05.008     Document Type: Article

References (43)

1. Baradari V., Huether A., Hopfner M., Schuppan D., Scherubl H. Antiproliferative and proapoptotic effects of histone deacetylase inhibitors on gastrointestinal neuroendocrine tumor cells. Endocr. Relat. Cancer 2006, 13:1237-1250.
2. Briscoe C.P., Tadayyon M., Andrews J.L., Benson W.G., Chambers J.K., Eilert M.M., Ellis C., Elshourbagy N.A., Goetz A.S., Minnick D.T., Murdock P.R., Sauls H.R., Shabon U., Spinage L.D., Strum J.C., Szekeres P.G., Tan K.B., Way J.M., Ignar D.M., Wilson S., Muir A.I. The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids. J. Biol. Chem. 2003, 278:11303-11311.
3. Brown A.J., Goldsworthy S.M., Barnes A.A., Eilert M.M., Tcheang L., Daniels D., Muir A.I., Wigglesworth M.J., Kinghorn I., Fraser N.J., Pike N.B., Strum J.C., Steplewski K.M., Murdock P.R., Holder J.C., Marshall F.H., Szekeres P.G., Wilson S., Ignar D.M., Foord S.M., Wise A., Dowell S.J. The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J. Biol. Chem. 2003, 278:11312-11319.
4. Cao X.X., Mohuiddin I., Ece F., McConkey D.J., Smythe W.R. Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma. Am. J. Respir. Cell Mol. Biol. 2001, 25:562-568.
5. Chen J.S., Faller D.V., Spanjaard R.A. Short-chain fatty acid inhibitors of histone deacetylases: promising anticancer therapeutics?. Curr. Cancer Drug Targets 2003, 3:219-236.
6. Conley B.A., Egorin M.J., Tait N., Rosen D.M., Sausville E.A., Dover G., Fram R.J., Van Echo D.A. Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors. Clin. Cancer Res. 1998, 4:629-634.
7. Covington D.K., Briscoe C.A., Brown A.J., Jayawickreme C.K. The G-protein-coupled receptor 40 family (GPR40-GPR43) and its role in nutrient sensing. Biochem. Soc. Trans. 2006, 34:770-773.
8. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J. Nutr. 2003, 133:2485S-2493S.
9. Dobbins R.L., Chester M.W., Daniels M.B., McGarry J.D., Stein D.T. Circulating fatty acids are essential for efficient glucose-stimulated insulin secretion after prolonged fasting in humans. Diabetes 1998, 47:1613-1618.
10. Duan H., Heckman C.A., Boxer L.M. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol. Cell. Biol. 2005, 25:1608-1619.
11. Glozak M.A., Seto E. Histone deacetylases and cancer. Oncogene 2007, 26:5420-5432.
12. Hinnebusch B.F., Meng S., Wu J.T., Archer S.Y., Hodin R.A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation. J. Nutr. 2002, 132:1012-1017.
13. Itoh Y., Kawamata Y., Harada M., Kobayashi M., Fujii R., Fukusumi S., Ogi K., Hosoya M., Tanaka Y., Uejima H., Tanaka H., Maruyama M., Satoh R., Okubo S., Kizawa H., Komatsu H., Matsumura F., Noguchi Y., Shinohara T., Hinuma S., Fujisawa Y., Fujino M. Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40. Nature 2003, 422:173-176.
14. Johnstone R.W. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 2002, 1:287-299.
15. Kimura I., Inoue D., Maeda T., Hara T., Ichimura A., Miyauchi S., Kobayashi M., Hirasawa A., Tsujimoto G. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41). Proc. Natl. Acad. Sci. USA 2011, 108:8030-8035.
16. Kimura M., Mizukami Y., Miura T., Fujimoto K., Kobayashi S., Matsuzaki M. Orphan G protein-coupled receptor, GPR41, induces apoptosis via a p53/Bax pathway during ischemic hypoxia and reoxygenation. J. Biol. Chem. 2001, 276:26453-26460.
17. Kotarsky K., Nilsson N.E., Flodgren E., Owman C., Olde B. A human cell surface receptor activated by free fatty acids and thiazolidinedione drugs. Biochem. Biophys. Res. Commun. 2003, 301:406-410.
18. Kramer O.H., Gottlicher M., Heinzel T. Histone deacetylase as a therapeutic target. Trends Endocrinol. Metab. 2001, 12:294-300.
19. Kuroiwa-Trzmielina J., de Conti A., Scolastici C., Pereira D., Horst M.A., Purgatto E., Ong T.P., Moreno F.S. Chemoprevention of rat hepatocarcinogenesis with histone deacetylase inhibitors: efficacy of tributyrin, a butyric acid prodrug. Int. J. Cancer 2009, 124:2520-2527.
20. Le Poul E., Loison C., Struyf S., Springael J.Y., Lannoy V., Decobecq M.E., Brezillon S., Dupriez V., Vassart G., Van Damme J., Parmentier M., Detheux M. Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation. J. Biol. Chem. 2003, 278:25481-25489.
21. Li R.W., Li C. Butyrate induces profound changes in gene expression related to multiple signal pathways in bovine kidney epithelial cells. BMC Genomics 2006, 7:234.
22. Marks P., Rifkind R.A., Richon V.M., Breslow R., Miller T., Kelly W.K. Histone deacetylases and cancer: causes and therapies. Nat. Rev. Cancer 2001, 1:194-202.
23. Milligan G., Stoddart L.A., Brown A.J. G protein-coupled receptors for free fatty acids. Cell Signal. 2006, 18:1360-1365.
24. Mohana Kumar B., Song H.J., Cho S.K., Balasubramanian S., Choe S.Y., Rho G.J. Effect of histone acetylation modification with sodium butyrate, a histone deacetylase inhibitor, on cell cycle, apoptosis, ploidy and gene expression in porcine fetal fibroblasts. J. Reprod. Dev. 2007, 53:903-913.
25. Muhlethaler-Mottet A., Meier R., Flahaut M., Bourloud K.B., Nardou K., Joseph J.M., Gross N. Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. Mol. Cancer 2008, 7:55.
26. Nielsen S., Jorgensen J.O., Hartmund T., Norrelund H., Nair K.S., Christiansen J.S., Moller N. Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients. Growth Horm. IGF Res. 2002, 12:425-433.
27. Nolan B., Duffy A., Paquin L., De M., Collette H., Graziano C.M., Bankey P. Mitogen-activated protein kinases signal inhibition of apoptosis in lipopolysaccharide-stimulated neutrophils. Surgery 1999, 126:406-412.
28. cip1/waf1. Int. J. Biochem. Cell Biol. 2007, 39:1367-1374.
29. Peters S.G., Pomare E.W., Fisher C.A. Portal and peripheral blood short chain fatty acid concentrations after caecal lactulose instillation at surgery. Gut 1992, 33:1249-1252.
30. Rosato R.R., Almenara J.A., Dai Y., Grant S. Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. Mol. Cancer Ther. 2003, 2:1273-1284.
31. Samuel B.S., Shaito A., Motoike T., Rey F.E., Backhed F., Manchester J.K., Hammer R.E., Williams S.C., Crowley J., Yanagisawa M., Gordon J.I. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc. Natl. Acad. Sci. USA 2008, 105:16767-16772.
32. Santini V., Gozzini A., Ferrari G. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr. Drug Metab. 2007, 8:383-393.
33. Siavoshian S., Segain J.P., Kornprobst M., Bonnet C., Cherbut C., Galmiche J.P., Blottiere H.M. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. Gut 2000, 46:507-514.
34. Stoddart L.A., Smith N.J., Milligan G. International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions. Pharmacol. Rev. 2008, 60:405-417.
35. Takai N., Desmond J.C., Kumagai T., Gui D., Said J.W., Whittaker S., Miyakawa I., Koeffler H.P. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells. Clin. Cancer Res. 2004, 10:1141-1149.
36. Tazoe H., Otomo Y., Kaji I., Tanaka R., Karaki S.I., Kuwahara A. Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions. J. Physiol. Pharmacol. 2008, 59(Suppl. 2):251-262.
37. Tazoe H., Otomo Y., Karaki S., Kato I., Fukami Y., Terasaki M., Kuwahara A. Expression of short-chain fatty acid receptor GPR41 in the human colon. Biomed. Res. 2009, 30:149-156.
38. Topping D.L., Clifton P.M. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol. Rev. 2001, 81:1031-1064.
39. von Engelhardt W., Bartels J., Kirschberger S., Meyer zu Duttingdorf H.D., Busche R. Role of short-chain fatty acids in the hind gut. Vet. Q 1998, 20(Suppl. 3):S52-S59.
40. Xiong Y., Miyamoto N., Shibata K., Valasek M.A., Motoike T., Kedzierski R.M., Yanagisawa M. Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41. Proc. Natl. Acad. Sci. USA 2004, 101:1045-1050.
41. Xu W.S., Parmigiani R.B., Marks P.A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26:5541-5552.
42. Yonezawa T., Kobayashi Y., Obara Y. Short-chain fatty acids induce acute phosphorylation of the p38 mitogen-activated protein kinase/heat shock protein 27 pathway via GPR43 in the MCF-7 human breast cancer cell line. Cell Signal. 2007, 19:185-193.
43. Yoo C.B., Jones P.A. Epigenetic therapy of cancer: past, present and future. Nat. Rev. Drug Discov. 2006, 5:37-50.